Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA20 Jan 2026, 05:18 UTC
AI-generated source summary
The analysis focuses on HIMS & Hers (HIMS) and its recent performance. Despite a nearly 40% stock price decline over the last six months, analysts have lowered their free cash flow expectations. However, the company has shown significant revenue growth, projecting $2.3 billion in revenue for 2025 and $298 million in 2027. Free cash flow to sales has improved, turning positive for two consecutive years and increasing to 17% in the most recent trailing twelve months. The forward P/E is trading near the midpoint of its historical range. The current intrinsic value per share is estimated at $31.68, down from a previous estimate of around $39, while the current market price is $31.32. Analysts have a 'Buy' rating on HIMS, suggesting it's a buying opportunity at current levels.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.